Paediatric DNA methylation profile scores: a systematic review and open-source atlas

Isabel K Schuurmans1, Serena Defina1, A P C Hermans1

  • 1Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Ebiomedicine
|May 22, 2026
PubMed

Insights

Methylation profile scores (MPSs) are increasingly used in early life research to understand exposures and health. This review highlights heterogeneity in studies and introduces DEMETRA, an atlas to guide selection of appropriate early-life MPSs.

Area of Science:

  • Epigenetics and Developmental Biology
  • Computational Biology and Bioinformatics

Background:

  • Methylation profile scores (MPSs) aggregate DNA methylation (DNAm) data into a single metric.
  • While widely used in adults, MPS application in early life (<18 years) is growing rapidly.
  • Early-life DNAm offers insights into developmental exposures and disease vulnerability.

Purpose of the Study:

  • To systematically review existing early-life MPS studies.
  • To identify common limitations and sources of heterogeneity in early-life MPS research.
  • To introduce DEMETRA, a resource for selecting appropriate early-life MPSs.

Main Methods:

  • Systematic literature review of 119 early-life MPS studies.
  • Analysis of 828 distinct MPSs across various exposures and traits.
  • Development of DEMETRA, a searchable atlas of early-life MPSs.

Main Results:

  • Significant heterogeneity observed in study design and reporting across the reviewed studies.
  • Frequent use of MPSs trained on mismatched age groups, tissues, platforms, and ancestries.
  • Potential for suboptimal MPS performance due to mismatched training data.

Conclusions:

  • Early-life MPS research exhibits considerable heterogeneity and methodological inconsistencies.
  • The DEMETRA atlas provides a valuable tool for researchers to identify and select suitable early-life MPSs.
  • Standardizing MPS application in early life is crucial for reliable results and advancing developmental epigenetics research.